Sponsored Instagram Story from Biogen Spokesperson’s Account Links to Tysabri (Video Included)

Brand: Tysabri (natalizumab), Intravenous Infusion
Parent Company: Biogen
Drug Type: Boxed Warning
Drug Category: Neurology
Campaign: Unbranded, Post-Launch
Targeting: Patients, Caregivers
Patient Website: https://www.tysabri.com/
HCP Website: https://www.tysabrihcp.com/